HOLLISTON, Mass.--(BUSINESS WIRE)--David Green, CEO of Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, was interviewed on Bloomberg TV’s “Market Makers” program on March 26.
Help employers find you! Check out all the jobs and post your resume.
